HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N- ((1S)- 1- (aminocarbonyl)- 2,2- dimethylpropyl)- 3- (3- hydroxy- 3- methylbutyl)- 2- oxo- 2,3- dihydro- 1H- benzimidazole- 1- carboxamide
cannabinoid 2 agonist; structure in first source
Also Known As:
PF-03550096
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Benzimidazoles: 245
N-((1S)-1-(aminocarbonyl)-2,2-dimethylpropyl)-3-(3-hydroxy-3-methylbutyl)-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide: 1
Experts
1.
Kikuchi, Akira
: 1 article (02/2008)
2.
Ohashi, Katsuyo
: 1 article (02/2008)
3.
Omura, Hirofumi
: 1 article (02/2008)
4.
Sugie, Yutaka
: 1 article (02/2008)
5.
Sugimoto, Hiromi
: 1 article (02/2008)
Related Diseases
1.
Hypersensitivity (Allergy)
02/01/2008 - "
These results indicate that PF-03550096 is a potent CB(2) agonist and possesses efficacy in a rat model of visceral hypersensitivity.
"
02/01/2008 - "
Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity.
"
Related Drugs and Biologics
1.
Ligands
2.
Cannabinoids